Abstract
An autopsy is a specialized surgical procedure consisting of external and internal examination of a deceased individual for the purposes of documenting abnormalities and determining or confirming medical diagnoses that may have contributed to their death. One of the benefits of an autopsy is the opportunity to collect and store biospecimens for the purposes of biobanking. This chapter outlines the procedures necessary to procure, store, and utilize biospecimens obtained during an autopsy. With the emergence of molecular diagnostics, this chapter also discusses factors that influence the integrity of autopsy biospecimens prior to procurement. These include the postmortem interval, as well as premortem factors such as the patient’s agonal state, biospecimen temperature, and pH.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marwick C (1995) Pathologists request autopsy revival. JAMA 273(24):1889–1891
Hull MJ, Nazarian RM, Wheeler AE et al (2007) Resident physician opinions on autopsy importance and procurement. Hum Pathol 38(2):342–350
Nolte KB, Taylor DG, Richmond JY (2002) Biosafety considerations for autopsy. Am J Forensic Med Pathol 23(2):107–122
Finkbeiner WE, Ursell PC, Davis RL (2009) Autopsy pathology: a manual and atlas, 2nd edn. Saunders/Elsevier, San Francisco, CA
Hynd MR, Lewohl JM, Scott HL et al (2003) Biochemical and molecular studies using human autopsy brain tissue. J Neurochem 85(3):543–562
Lee J, Hever A, Willhite D et al (2005) Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J 19(10):1356–1358
Blair JA, Wang C, Hernandez D et al (2016) Individual case analysis of postmortem interval time on brain tissue preservation. PLoS One 11(3):e0151615. https://doi.org/10.1371/journal.pone.0151615
Yong WH, Dry SM, Shabihkhani M (2014) A practical approach to clinical and research biobanking. Methods Mol Biol 1180:137–162
Espina V, Mueller C, Edmiston K et al (2009) Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl 3(8):874–882
Barton AJ, Pearson RC, Najlerahim A, Harrison PJ (1993) Pre- and postmortem influences on brain RNA. J Neurochem 61(1):1–11
Phang TW, Shi CY, Chia JN, Ong CN (1994) Amplification of cDNA via RT-PCR using RNA extracted from postmortem tissues. J Forensic Sci 39(5):1275–1279
Vennemann M, Koppelkamm A (2010) Postmortem mRNA profiling II: practical considerations. Forensic Sci Int 203(1–3):76–82
Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118(1–2):60–71
Kingsbury AE, Foster OJ, Nisbet AP et al (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28(2):311–318
Li JZ, Vawter MP, Walsh DM et al (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13(6):609–616
Tomita H, Vawter MP, Walsh DM et al (2004) Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55(4):346–352
Stan AD, Ghose S, Gao XM et al (2006) Human postmortem tissue: what quality markers matter? Brain Res 1123(1):1–11
Mall G, Eisenmenger W (2005) Estimation of time since death by heat-flow Finite-Element model. Part I: Method, model, calibration and validation. Leg Med (Tokyo) 7(1):1–14
Schroeder A, Mueller O, Stocker S et al (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7(3):1–14
Ma MJ, Perry A, Brat DJ (eds) (2010) Biopsy pathology of neurodegenerative disorders in adults. Practical surgical neuropathology: a diagnostic approach. Churchill Livingstone/Elsevier, Philadelphia, pp 566–570
Ellison D, Love S et al (2013) Prion diseases. In: Neuropathology: a reference text of CNS pathology, 3rd edn. Mosby/Elsevier, USA, p 676
Liu A, Pollard K (2015) Biobanking for personalized medicine. In: Biobanking in the 21st century. Springer International Publishing, Switzerland, pp 55–68
Molina DK (2010) Collection and selection of toxicologic specimens. In: Handbook of forensic toxicology for medical examiners. CRC Press/Taylor & Francis Group, New York, pp 1–6
Teunissen CE, Tumani H, Bennett JL et al (2011) Consensus guidelines for CSF and blood biobanking for CNS biomarker studies. Mult Scler Int 2011:246412
Acknowledgments
This work was supported in part by NIH:NCI P50-CA211015, NIH:NIMH U24 MH100929, the Art of the Brain Foundation, and the Henry E. Singleton Brain Cancer Research Program.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tashjian, R.S., Williams, R.R., Vinters, H.V., Yong, W.H. (2019). Autopsy Biobanking: Biospecimen Procurement, Integrity, Storage, and Utilization. In: Yong, W. (eds) Biobanking. Methods in Molecular Biology, vol 1897. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8935-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8935-5_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8933-1
Online ISBN: 978-1-4939-8935-5
eBook Packages: Springer Protocols